Schedule 13G ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2022-12-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,647,430
- Percent of class
- 7.0500%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-23-000299
- Form type
- SC 13G
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Jan 23, 2023
- Reporting period
- Dec 30, 2022
- Description
- Schedule 13G beneficial ownership